Cited by 45Hormonal and reproductive studiesHypothalamic control of reproductive hormonesAdrenal Hormones and Disorders

Somatic and psychological effects of low-dose aromatase inhibition in men with obesity-related hypogonadotropic hypotestosteronemia

Open access
Loves, Sandra, de Jong, Jos, van Sorge, Adriaan, Telting, Darryl, Tack, Cees J, Hermus, Ad, Westerterp, Klaas, de Boer, Hans·2013·European Journal of Endocrinology

Abstract

Introduction: Reduced testosterone levels are frequently observed in obese men. Increased aromatase activity may be an etiological factor. Objective: In this study, we evaluate the clinical effects of aromatase inhibition in obesity-related hypogonadotropic hypotestosteronemia (OrHH). Methods: Double-blind, placebo-controlled, 6-month trial in 42 obese men with a BMI >35 kg/m 2, and a serum total testosterone <10 nmol/l. All patients started on one tablet of 2.5 mg/week, with subsequent dose escalation every month until a serum total testosterone of 20 nmol/l was reached. Endpoints: Psychological function, body composition, exercise capacity, and glucose, lipid, and bone metabolism. Results: Thirty-nine patients completed the study according to protocol. Letrozole decreased serum estradiol from 119.1±10.1 to 59.2±6.1 pmol/l (P<0.001), and increased serum LH from 3.3±0.3 to 8.8±0.9 U/l (P<0.0001) and serum total testosterone from 8.6±0.7 to 21.5±1.3 nmol/l (P<0.0001). Significant effects on the predefined endpoints were not observed. Conclusion: Despite a marked rise in serum testosterone, low-dose aromatase inhibition had no somatic or psychological effects in men with OrHH.

Integrity signals

Registry

Crossref · 10.1530/eje-13-0190

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

1 of the 41 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Loves, S., de Jong, J., van Sorge, A., Telting, D., Tack, C. J., Hermus, A., Westerterp, K., & de Boer, H.
Affiliations
  • Rijnstate Hospital (NL)
  • Radboud University Medical Center (NL)
  • Maastricht University (NL)
Corresponding author
Loves, Sandra
Venue
European Journal of Endocrinology
Published
2013-11
Volume
169
Issue
5
Pages
705-714
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2157274344
Cited by
45
References
41
Citations by year
2026: 5 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 6
FWCI
3.15
Type
journal article
Language
en
Licence
other-oa
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
aromatase inhibition, letrozole, testosterone replacement therapy, estradiol, luteinizing hormone, body composition, exercise capacity, bone metabolism, lipid metabolism, glucose metabolism, psychological functioning, obese men
MeSH terms
Letrozole, Adult, Androgens, Blood Glucose, Body Composition, Energy Intake, Double-Blind Method, Estradiol, Hormones, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Neuropsychological Tests, Nitriles, Obesity, Morbid, Psychometrics, Testosterone, Triazoles, Bone Density, Body Mass Index, Exercise Tolerance, Aromatase Inhibitors, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review